NPPB and Miyoshi myopathy: The Mayo AL staging systems incorporate troponin T, NT pro-BNP, and more recently serum immunoglobulin FLCs.15, 16 Unlike MM which relies heavily on cytogenetic aberrations for risk stratification, until recently there were not any established cytogenetic prognostic markers for AL.